Document Detail


Functional interactions between Lmo2, the Arf tumor suppressor, and Notch1 in murine T-cell malignancies.
MedLine Citation:
PMID:  21427293     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
LMO2 is a target of chromosomal translocations in T-cell tumors and was activated by retroviral vector insertions in T-cell tumors from X-SCID patients in gene therapy trials. To better understand the cooperating genetic events in LMO2-associated T-cell acute lymphoblastic leukemia (T-ALL), we investigated the roles of Arf tumor suppressor loss and Notch activation in murine models of transplantation. Lmo2 overexpression enhanced the expansion of primitive DN2 thymocytes, eventually facilitating the stochastic induction of clonal CD4(+)/CD8(+) malignancies. Inactivation of the Arf tumor suppressor further increased the self-renewal capacity of the primitive, preleukemic thymocyte pool and accelerated the development of aggressive, Lmo2-induced T-cell lympholeukemias. Notch mutations were frequently detected in these Lmo2-induced tumors. The Arf promoter was not directly engaged by Lmo2 or mutant Notch, and use of a mouse model in which activation of a mutant Notch allele depends on previous engagement of the Arf promoter revealed that Notch activation could occur as a subsequent event in T-cell tumorigenesis. Therefore, Lmo2 cooperates with Arf loss to enhance self-renewal in primitive thymocytes. Notch mutation and Arf inactivation appear to independently cooperate in no requisite order with Lmo2 overexpression in inducing T-ALL, and all 3 events remained insufficient to guarantee immediate tumor development.
Authors:
Louise M Treanor; Emmanuel J Volanakis; Sheng Zhou; Taihe Lu; Charles J Sherr; Brian P Sorrentino
Related Documents :
3865013 - Spontaneous urinary bladder tumors in da/han rats: a feasible model of human bladder ca...
10418173 - Immunohistochemical analysis of nm23-h1 protein in bladder cancer.
22287313 - Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous c...
Publication Detail:
Type:  Journal Article     Date:  2011-03-22
Journal Detail:
Title:  Blood     Volume:  117     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-05-20     Completed Date:  2011-08-09     Revised Date:  2012-09-19    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  5453-62     Citation Subset:  AIM; IM    
Affiliation:
Division of Experimental Hematology, Department of Hematology, St Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adaptor Proteins, Signal Transducing
Animals
Cell Transformation, Neoplastic / genetics,  metabolism
Cocarcinogenesis
Cyclin-Dependent Kinase Inhibitor p16 / genetics,  metabolism*
DNA-Binding Proteins / deficiency,  genetics,  metabolism*
Disease Progression
Female
Gene Expression
LIM Domain Proteins
Loss of Heterozygosity
Male
Metalloproteins / deficiency,  genetics,  metabolism*
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Mutation
Neoplastic Stem Cells / metabolism
Precursor Cells, T-Lymphoid / metabolism
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics,  metabolism*
Promoter Regions, Genetic
Receptor, Notch1 / genetics,  metabolism*
Signal Transduction
Chemical
Reg. No./Substance:
0/Adaptor Proteins, Signal Transducing; 0/Cdkn2a protein, mouse; 0/Cyclin-Dependent Kinase Inhibitor p16; 0/DNA-Binding Proteins; 0/LIM Domain Proteins; 0/Lmo2 protein, mouse; 0/Metalloproteins; 0/Notch1 protein, mouse; 0/Receptor, Notch1
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Human T-lymphotropic type 1 virus p30 inhibits homologous recombination and favors unfaithful DNA re...
Next Document:  The Role of Angiotensin Receptor Blockers in Patients with Angiotensin-Converting Enzyme Inhibitor-I...